3,4-dihydroxyphenylacetic acid has been researched along with Diabetes Mellitus, Adult-Onset in 4 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma dopamine and its metabolites in NIDDM following protein tended to be greater than in C." | 2.68 | Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. ( Fukuchi, S; Ishii, H; Sanada, H; Shigetomi, S; Watanabe, H; Yamada, ZO, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreno Uclés, R | 1 |
| González-Sarrías, A | 1 |
| Espín, JC | 1 |
| Tomás-Barberán, FA | 1 |
| Janes, M | 1 |
| Cheng, H | 1 |
| Finley, J | 1 |
| Greenway, F | 1 |
| Losso, JN | 1 |
| Liu, M | 1 |
| Wang, L | 1 |
| Huang, B | 1 |
| Lu, Q | 1 |
| Liu, R | 1 |
| Anderzhanova, E | 1 |
| Covasa, M | 1 |
| Hajnal, A | 1 |
| Shigetomi, S | 1 |
| Yamada, ZO | 1 |
| Ishii, H | 1 |
| Sanada, H | 1 |
| Watanabe, H | 1 |
| Fukuchi, S | 1 |
1 trial available for 3,4-dihydroxyphenylacetic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Cyclic AMP; Diabetes Mellitus, Type 2; Diet; Dietary Proteins | 1995 |
3 other studies available for 3,4-dihydroxyphenylacetic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effects of red raspberry polyphenols and metabolites on the biomarkers of inflammation and insulin resistance in type 2 diabetes: a pilot study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biomarkers; Diabetes Mellitus, Type 2; Health Promotion; Humans; Inf | 2022 |
3,4-Dihydroxyphenylacetic acid ameliorates gut barrier dysfunction via regulation of MAPK-MLCK pathway in type 2 diabetes mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents; Cytokines; Diabetes Mellitus, Typ | 2022 |
Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Dopami | 2007 |